Infanrix hexa
201330
Approved mab completed
Quick answer
Infanrix hexa for Acellular Pertussis is a Approved program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Acellular Pertussis
- Phase
- Approved
- Modality
- mab
- Status
- completed